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Snmli'nary 
To determine events that transpire during the earliest stages of human T cell development, we 
have studied fetal tissues before (7 wk), during (8.2 wk), and after (9.5 wk to birth) colonization 
of the fetal thymic rudiment with hematopoietic stem cells. Calculation of the approximate volumes 
of the 7- and 8.2-wk thymuses revealed a 35-fold increase in thymic volumes during this time, 
with 7-wk thymus height of 160 gM and volume of 0.008 mm  3, and 8.2-wk thymus height 
of 1044 gM  and volume of 0.296  mm  3.  Human thymocytes in  the 8.2-wk  thymus were 
CD4+CD8o~ + and cytoplasmic CD3e+cCD38+CD8fl -  and CD3~'-. Only 5% of 8-wk thymo- 
cytes were T  cell receptor (TCR)-fl +, <0.1% were TCR-3, +,  and none reacted with mono- 
clonal antibodies against TCR-& During the first 16 wk of gestation, we observed developmen- 
tally regulated expression of CD2 and CD8fl (appearing at 9.5 wk), CDla,b, and c molecules 
(CDlb, then CDlc, then CDla), TCR molecules (TCR-fl, then TCR-/$), CD45RA and CD45RO 
isoforms, CD28 (10 wk), CD3~" (12-13 wk), and CD6 (12.75 wk). Whereas CD2 was not ex- 
pressed at the time of initiation of thymic lymphopoiesis, a second CD58 ligand, CD48, was 
expressed at 8.2 wk, suggesting a role for CD48 early in thymic development. Taken together, 
these data define sequential phenotypic and morphologic changes that occur in human thymus 
coincident with thymus colonization by hematopoietic stem cells and provide insight into the 
molecules that are involved in the earliest  stages of human T  cell development. 
S 
tudy of the  earliest  stages  of human T  cell  develop- 
ment provides important information regarding the mol- 
ecules involved in the complex series of events that transpire 
during establishment of the T cell repertoire. Knowledge of 
the sequence of expression  of developmentally regulated T 
cell functional molecules can provide insight into mechanisms 
of normal T  cell maturation, and can provide information 
necessary to form hypotheses regarding molecular mechanisms 
of thymus growth. We must understand the stages of normal 
T cell development to devise successful strategies for immune 
reconstitution of a variety of acquired and congenital T cell 
immune deficiency syndromes. 
Whereas enormous progress has been made in our under- 
standing of the earliest stages of murine (for review see refer- 
ence 1) and avian (for review see reference 2) thymus devel- 
opment, the sequence of events at the time of colonization 
of the human thymus with hematopoietic stem cells has not 
been studied. We have previously studied human fetal thymuses 
at 7 wk, before lymphoid colonization of the thymus (3), 
and at 9.5 wk of gestation, 1.5 wk after hematopoietic stem 
cell migration to the thymus (3-5). Our prior efforts to study 
lymphoid fetal thymus at earlier than 9.5 wk of gestational 
age were thwarted by lack of availability of thymus tissues 
at the time of colonization of the thymus, the small size of 
the human thymus at 8 wk ('~1 mm ￿  i mm x  0.5 mm), 
and the frequent contamination of first trimester fetal tissue 
with placental tissue containing CD7 +,  decidual granular 
lymphocytes of NK lineage (6, 7). Thus, the phenotypic and 
morphologic events that occur at the initiation of lymphopoi- 
esis in the human thymus have not been observed.  In this 
study, we have definitively identified the human thymus in 
fetal thorax at 8.2 wk of gestation, defined its three-dimen- 
sional structure, and determined the reactivity of 64 mAbs 
with this tissue,  as well as with fetal thymuses at 9.5,  10, 
12.75, 13, and 16 wk of gestational age. Our data document 
the extraordinary thymus growth that occurs at the time of 
stem cell colonization of the thymus and demonstrate de- 
velopmentally regulated expression of a large series of lym- 
phoid and thymic microenvironment molecules. 
Materials and Methods 
Thymic Tissue.  Fetal  tissues were obtained as discarded  mate- 
rial from the Pathology Department, Duke University Medical 
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of surgery for ectopic pregnancy as described (3-5).  Gestational 
age, determined by crown-rump  length,  menstrual records when 
available, and fetal part morphology,  ranged from 7 to 34 wk of 
gestation (3-5).  Fetal tissues 50 (7 wk; reference 3) and 58 (8.2 
wk) were serially sectioned through  the thorax and neck area in 
4-#M sections and hematoxylin and eosin (H&E)l-stained sections 
were prepared every 40 #M (50; reference 3) or 80 #M (58). In 
these tissues, the thymus was identified as a keratin-containing struc- 
ture in the neck lateral to the trachea and esophagus (7 wk; refer- 
ence 3) or in the upper mediastinum  anterior to the trachea and 
great vessels (8.2 wk; reference 8). 
Computer Reconstruction of 7- and 8.2-wk Fetal Thymuses.  Three- 
dimensional reconstruction  of thymus 50 (7 wk) and thymus 58 
(8.2 wk) were performed using the PC3D three-dimensional recon- 
struction  program,  version 5.0 Clandel Scientific, Corte Madera, 
CA). For 8.2-wk fetal thymus 58, thymus perimeters were traced 
from  14 sections. 
Monoclonal and Polyclonal  Antibodies.  Monoclonal  and polyclonal 
antibodies used in this study and their sources are listed in Table 
1. Each antibody was used at saturating  concentrations. 
Immunofluorescence Assays.  Indirect immunofluorescence (IF) 
assays were performed on acetone-fixed 4-#M tissue sections as de- 
scribed (3, 4) by use of FITC-conjugated goat anti-mouse Ig (Kir- 
kegaard and Perry Labs., Inc., Gaithersburg, MD). Indirect IF assays 
on cell suspensions were performed as described (3-5) and analyzed 
on either a FACS  |  Star Plus (Becton Dickinson & Co., Mountain 
View, CA) or profile flow cytometer (Coulter Corp., Hialeah, FL). 
IF assays were usually performed in duplicate, and select mAb IF 
assays were repeated three  times. 
Results 
Computer-assisted Three-dimensional Reconstruction of Fetal 
Thymus 50 Before Thymic Colonization and Fetal Thymus 58 
at the Time of Thymic Colonization.  Fetal thymus  50 at  7 
wk of gestation (before lymphoid colonization) was devoid 
of CD45 § cells and consisted of only two spherical thymic 
rudiments, each '~160  x  180  x  200 #M, in the lateral neck 
areas (3). Only four H&E-stained sections were available for 
this tissue; thus, a fully interpretable  computerized image could 
not be generated.  The calculated total volume (both rudi- 
ments) of nonlymphoid thymus 50 at 7 wk was 0.008 mm  3. 
In contrast,  8.2-wk  thymus  58 was filled  with  CD45 + 
hematopoietic cells, and was 1,044 #M in length,  1,200 #M 
wide, and 480 #M deep. The 8.2-wk right and left thymic 
rudiments were located anterior to the esophagus,  trachea, 
and great vessels in the upper thorax  (Fig.  1).  Computer- 
assisted  reconstruction  of the 8.2-wk fetal  thymus demon- 
strated that the lower lobes of the thymus had fused, whereas 
the right  and left upper thymic rudiments  remained  sepa- 
rate. The right thymic rudiment was a nonlobulated cylinder, 
whereas the left thymic rudiment was just beginning to be- 
come lobulated. Most published images of fetal thymus at 
this stage of development show two elongated cylindrical tubes 
1  Abbreviations used in this paper: c, cytoplasmic; H&E, hematoxylin and 
eosin; ICAM, intercellular adhesion molecule; IF, immunofluorescence; 
s, surface; TdT, terminal deoxynucleotidyl  transferase; TE, thymic epithe- 
lial; VLA, very late antigen of activation. 
on each side of the neck, meeting in the middle (9).  How- 
ever, analysis of the actual three dimensional structure of the 
8.2-wk thymus demonstrated a globular structure, with the 
right and left lobes beginning to rotate around a central axis 
and intertwine. The calculated volume of 8.2-wk thymus 58 
was 0.296  mm 3.  Thus,  we estimated  that  the  thymus  in- 
creases in volume ~35-fold from 7 wk (nonlymphoid stage) 
to 8.2 wk  (after lymphoid colonization). 
Expression of Human T Cell Lineage Molecules During Early 
Thymus Development.  The expression of a panel of T  cell 
lineage molecules (Table 1) was studied in 8.2-,  9.5-,  10-, 
12.75-,  13-,  and 16-wk fetal thymuses (Table 2). Studies in 
thymuses 48 (9.5 wk), 22 (10 wk) and 40 (12.75 wk) have 
been reported previously for some of the molecules studied 
(3-5) and are included in Table 2 for completeness. The new 
and striking findings in this study were (a) lack of expression 
of CD2 at the time of thymic colonization  at 8.2 wk;  (b) 
lack of expression at  8.2 wk of CD8/3 with  expression of 
CD8o~;  and (c) sequential expression of CDlb,  then CDlc, 
then CDla molecules from 8.2 to 13 wk. Fig. 2 shows lack 
of CD2 and CD8B expression at 8.2 wk, with  all 8.2-wk 
thymocytes CD4+CD8ot+CD7+,  and CD5 §  The finding 
that most thymocytes at this stage were CD4 § CD8 § (double 
positive) was also surprising,  since most murine thymocytes 
at the stage analogous to the 8.2-wk human thymus develop- 
ment (11 d) are CD4-CDS-  (10, 11). By 10 wk, all thymo- 
cytes expressed CD8/~, followed by appearance  of CDScffj5 + 
and CDSot/~-  subsets in the thymic medulla at  12.75 wk 
(Table 2). By 12.75 wk, CDla, -b, and -c expression was similar 
to that seen in postnatal thymus, with the typical CD1 pat- 
tern of all cortex and few medullary cells being CD1 +. 
Expression of CD45 Molecule Isoforms During Early Human 
T Cell Development.  It has been suggested that CD45tLA + 
human  thymocytes represent the generative thymocyte lin- 
eage destined for positive selection and thymic export, whereas 
CD45RO §  thymocytes  are  destined  to  undergo  negative 
or no selection and die intrathymically (12).  We found few 
CD45RA +  cells  in  8.2-  and  9.5-wk  thymuses  (Fig.  3,  B 
and E),  whereas  in  12.75-wk  thymus,  a  distribution  of 
CD45RA § cells similar to postnatal thymus was seen,  that 
is,  scattered  cortical  thymocytes  were  CD45RA § ,  with 
large clusters of CD45RA + thymocytes in the thymic me- 
dulla (Fig. 3 H). Similarly, by 10-12.75 wk, most thymocytes 
were CD45RO + (Fig.  3 I), raising the possibility of onset 
of thymocyte-negative selection during this period (13, 14). 
Expression of TCR-associated Molecules During Early T Cell 
Development.  Data for percentages ofceUs positive for TCR-B, 
TCR-cS, and CD3e in thymuses 48, 22, 5, and 40 have been 
previously reported (3-5). Whereas CD3e and CD3r  were 
present in 8.2-wk thymus in most thymocytes (Fig. 4, D and 
E), expression of CD3~" chain was not observed until 10 wk 
(Fig. 4 F and Table 3). By 12.75 wk, most medullary thymo- 
cytes were CD3~  "+ . CD3g" expression gradually increased  in 
cortical thymocytes until birth, when CD3~'mAb 2H2 reacted 
with a pattern (cortical thymocytes low positive, medullary 
thymocytes high positive) similar to a reactivity pattern of 
CD3c mAb,  Leu 4  (not  shown). 
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mAb  Specificity  Source 
A.  McMichael, Institute  of Molecular Medicine, John Radcliffe Hospital, 
NA1/34  CDla  Oxford, UK 
10DR2  CDla  2nd IWLDA 
NUT  CDlb  2nd IWLDA 
4A76  CDlb  2nd IWLDA 
M241  CDlc  2nd IWLDA 
35.1  CD2  J.  Hansen,  University  of Washington, Seattle, WA 
OKTll  CD2  American Type Culture Collection,  Rockville,  MD 
Leu 4  CD3e  R. Evans, University  of Rochester,  Rochester,  NY 
SP34  CD36  C. Terhorst, Harvard  University,  Boston,  MA 
2H2  CD~"  P.  Anderson,  Harvard  University,  Boston,  MA 
Leu 3a  CD4  R. Evans, University  of Rochester,  Rochester,  NY 
T101  CD5  2nd IWLDA 
12.1  CD6  P.  Martin,  University  of Washington, Seattle, WA 
3Ale  CD7  B.  Haynes, Duke University,  Durham, NC 
Leu 2a  CD8~x  R. Evans, University  of Rochester,  Rochester,  NY 
25T8-SH7  CDSfl  E. Reinherz, Harvard  University,  Boston,  MA 
TS1/22  CD11a/LFA-1c~  T. Springer,  Harvard  University,  Boston,  MA 
MO-1  CD11b/MO-1  R.  Todd, University  of Michigan,  Ann Arbor, MI 
Leu M3  CD14  R.  Winchester,  Columbia  University,  NY 
4F7  CD16  P.  Anderson,  Harvard  University,  Boston,  MA 
TAC  CD25  T. Waldmann,  National  Institutes  of Health,  Bethesda, MD 
9.3  CD28  P.  Martin,  University  of Washington, Seattle, WA 
KOLT2  CD28  2nd IWLDA 
MY9  CD33  Coulter Corp., Hialeah,  FL 
HPCA-1  CD34  Becton Dickinson  & Co.,  Mountain  View,  CA 
F10-89-4  CD45  J.  Fabre, R. Dalchau,  University  of London, London, UK 
F8-11-13  CD45RA  J.  Fabre, R. Dalchau,  University  of London, London, UK 
UCHL-1  CD45RO  P.  Beverly, University  College,  Middlesex School of Medicine, London, UK 
6.28  CD48  5th IWLDA 
Mo2PT501  CD48  5th IWLDA 
TS2/7  CD49a/VLA-1  M.  Hemler, Harvard  University,  Boston,  MA 
12F1  CD49b/VLA-2  M.  Hemler, Harvard  University,  Boston,  MA 
A3-IIF5  CD49c/VLA-3  5th IWLDA 
B5G10  CD49d/VLA-4  M. Hemler, Harvard  University,  Boston,  MA 
K20  CD29/VLA-B1  A. Bernard,  University  of Nice,  Nice,  France 
BQ16  CD49f/VLA-6  5th IWLDA 
RR-1  CD54/ICAM-1  R.  Rothlein, Boehringer  Ingelheim  Pharmaceuticals, Ridgefield,  CT 
TS2/9  CD58/LFA-3  T. Springer,  Harvard  University,  Boston,  MA 
H19  CD59  A.  Bernard,  University  of Nice,  Nice,  France 
5E9  CD71/transferrin receptor  B.  Haynes,  Duke University,  Durham, NC 
10F9  CD99/E2-MIC2  B.  Haynes,  Duke University,  Durham, NC 
flF1  TCR-fl  M. Brenner,  Harvard  University,  Boston,  MA 
continued 
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mAb  Specificity  Source 
Polyclonal  TCR-y 
TlgammaA  TCR Vy9 
TCR61  TCR-6 
A13  TCR V61 
BB3  TCR V62 
TCS61  TCR V61-J61 
HAE2a  VCAM-1 
ELAM-1  E-selectin 
LAM1.3  L-selectin 
oeVWF  VWF 
133  B7-1 
TE-4  TE-4 
TE-3  TE-3 
TE-8  TE-8 
AE-1  Keratin 
12-1/2  HTLV-I p19  and 
46KD keratin 
TE-19  A blood  group 
A2B5  GQ gangliosides 
6D5(V2)  Vessels 
TE-7  TE-7 
7401  Tissue transglutaminase 
HB15a  Dendritic  cells 
M.  Brenner,  Harvard University,  Boston,  MA 
T.  Hercend,  Gustave  Roussy Institute,  Villejiuf,  France 
M.  Brenner,  Harvard University,  Boston,  MA 
L.  Moretta,  University of Genoa,  Genoa,  Italy 
L.  Moretta,  University of Genoa,  Genoa,  Italy 
T  Cell Sciences Inc., Cambridge,  MA 
T.  Tedder,  Duke University, Durham,  NC 
T.  Tedder, Duke University,  Durham,  NC 
T.  Tedder,  Duke University, Durham,  NC 
C.  Greenberg,  Duke University,  Durham,  NC 
L.  Nadler,  Harvard University,  Boston,  MA 
B.  Haynes,  Duke University, Durham,  NC 
B.  Haynes, Duke University,  Durham,  NC 
B.  Haynes,  Duke University,  Durham,  NC 
H.  Sun,  New York University, New York 
M.  Robert-Guroff, National Institutes  of Health, Bethesda,  MD 
B.  Haynes,  Duke University,  Durham,  NC 
G.  Eisenbarth,  University  of Colorado,  Denver, CO 
B.  Haynes,  Duke University, Durham,  NC 
B.  Haynes,  Duke University, Durham,  NC 
C.  Greenberg,  Duke University, Durham,  NC 
T.  Tedder,  Duke University,  Durham,  NC 
IWLDA,  International Workshop on Leukocyte Differentiation Antigen. 
Figure  1.  H&E-stained  sections of fetal tissue 58. A shows single right and double left thymus lobes (arrowheads),  trachea (7), esophagus (E), and 
left lung (L).  x 50. B shows left thymus lobe. Small arrowhead on upper thymus left lobe in A shows same point at small arrowhead of magnified 
left thymus lobe in/~  x800. Table  2.  Expression  of Thymocyte Lineage Molecules During Early Thymus Development 
Fetal  Molecule  analyzed 
thymus 
no.  Age  CD34  CD7  CDla  CDlb  CDlc  CD2  CD4  CD8~t  CD8~  CD5  CD6  CD28 
wk 
58  8.2  C,V+  +  -*  +*  +/-  -  +  +  -  +  -  - 
48  9.5  C,V+  +  +/-  +/-  +/-  +  +  +  +/-  ND  ND  - 
22  10.0  C,V +  +  +  /  -  +  /  -  +  /  -  +  +  +  +  ND  _  s  +  /  _ 
40  12.75  C,V+  +  +/-  +/-  +/-  +  +  +/-  +/-  +  +  + 
56  13.0  C,V +  +  +  /  -  +  /  -  +  /  -  +  +  +  /  -  +  /  -  +  +  + 
57  16.0  C,V+  +  +/-  +/-  +/-  +  +  +/-  +/-  +  +  + 
* mAb nonreactive or  rare cell +  (2-4/slide);  + / -,  subset  of cells reactive. 
# All cells reactive in the appropriate thymus zone (e.g.,  for CD1,  all cortical thymocytes reactive; for CDS,  all thymocytes reactive; for CD6,  all 
medullary thymocytes reactive, etc.).  For CDlb at 8.2-wk  and CDSot  and CD83 at  10 wk,  all thymocytes were  +.  For CD83  at  12.75,  13, and 
16 wk,  + /  -  signifies cortex+  and a subset of medullary thymocytes+;  at 9.5 wk,  +/-  for CDSB signifies that only a subset of total thymocytes 
were  reactive. 
S With  mAb T12,  thymocytes  at  10  wk  were very dim  +. 
C,V+,  capsule and thymic vessels  +.  Beginning at 9.5  wk,  rare CD34+  mononuclear cells also were  seen scattered in thymus,  but from 8.2  to 
16  wk,  most  thymocytes  were  CD34-.  ND, not  done. 
TCR-3 expression was acquired in increasing percentages 
of thymocytes during  the  first  trimester,  with  only rare 
(*5%) 8.2-wk thymocytes being TCR-3 + (Fig. 4 A). Only 
very rare TCR-3, ceils were found to be present at 8.2 wk 
by use of a polyclonal anti-TCR-3, antibody or the anti-V3,9 
mAb, T13~A (not shown). No thymocytes at 8.2 wk expressed 
TCR-~ as determined by mAbs TCR-61 (anti-TCR-6),  BB3 
(anti-V~2) (Fig. 4 B) or A13 (anti-V~l).  Thus, in the human 
fetal thymus, TCR-3 expression  was first observed coinci- 
dent with the appearance  of rare  TCR-q, + cells. 
As previously reported (4), TCR-6 expression peaked (11% 
of T cells) at 9.5 wk, the time of first appearance of TCR-5 
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Figure 2.  Analysis ofthymocyte 
phenotype  at  the  time  of  initial 
colonization of the human thymus. 
Reactivity of human 8.2-wk thymo- 
cytes  are  shown  in A  with  CD7 
mAb 3Ale,  in B  with CD4  mAb 
Leu 3a, and in C with CD8a mAb 
Leu  2a.  However,  no  thymocytes 
were reactive with the CD8fl mab 
25T8-5H7  (D).  All  thymocytes 
were CD5 §  with mAb T101 (E). 
Surprisingly, no thymocytes reacted 
with either CD2 mAb 35.1 (F) or 
OKTll  (not  shown).  There  was 
also  asynchronous  expression  of 
CDla, CDlb, and CDlc molecules. 
CDla mAb NA1/34  only reacted 
with rare scattered macrophage-like 
cells  (G),  whereas  CDlb  mAb 
NUT2  reacted  with  all  8.2-wk 
thymocytes (H). CDlc mAb M241 
only reacted with ".,1% of 8.2-wk 
thymocytes (I). Dotted line shows 
borders  of thymus,  x400. Figure  3.  Ontogeny of expression of CD45 isoforms 
during the earliest stages of  human thymus development. 
(A-C) 8.2-wk fetal thymus 58; (D-F) 9.5-wk  fetal thymus 
48; (G-I) 12.75-wk fetal thymus 40. (A, D, and G) Re- 
activity of the pan-CD45 mAb F-10-89-4; (B, E, and H) 
reactivity of the CD45RA mAb F-8-11-13;  and (C, F,, and 
I) reactivity of the CD45RO  mAb UCHL-1. x400. 
(Table 3).  In this study with anti-V/~l and ova2 mAbs, we 
found that the ratio of V/i2/V/~I T  cells varied  over time 
of gestation (Fig. 5). There were two general peaks of V#2 
predominance over V/il TCR-8 + cells, initially at 9.5 wk 
and later beginning at  16 wk and continuing through the 
last trimester. Even though the ratio of V#2/V81 remained 
high until birth, the precentage of total TCR-/~  + thymocytes 
remained low during the second and third trimesters. 
Expression  of  Adhesion Molecules  During  Early  Human T Cell 
Development.  In contrast to lack of reactivity of CD2 mAbs 
with the 8.2-wk thymus, LFA-3 (CD58) mAb TS2/9 reacted 
with 8.2-wk thymic epithelium, raising the question of the 
presence of a second intrathymic CD58 ligand at 8.2 wk (Fig. 
6 B).  Recently, the CD48 molecule in mouse and humans 
has been shown to bind to CD58, although the significance 
of CD58-CD48 interactions in humans has been questioned 
(15). Using two CD48 mAbs (6.28  and MO2FTS01), we 
found that  thymocytes from 8.2 wk  through birth were 
CD48 + (Fig.  6 B).  Two additional putative CD2 ligands, 
CD59 (H19/DAF)  (16) and CD99 (E2/MIC2)  (17), were 
found to be present in 8.2-wk thymus (Fig.  6,  C  and D). 
Intercellular adhesion molecule 1 (ICAM-1) (CD54)-LFA-1 
(CD11a/CD18) interactions are also important in thymic ep- 
ithelial (TE)-thymocyte interactions (18, 19). At 8.2 wk (Fig. 
7, E and F), and throughout gestation (18, 20), thymocytes 
were CD11a +,  and TE cells were ICAM-1 +. 
CD49 (very late antigen of activation [VLA] CD49/CD29) 
molecules are a family of integrins that mediate cell binding 
to a variety of extracellular matrix and cell surface molecules 
(21). In the 8.2-wk thymus, VLA-1 mAbs reacted with thymic 
vessels, VLA-2 mAb reacted throughout with thymic stromal 
cells (fibroblasts and TE cells), VLA-3 mAb A3-IIF5 reacted 
with TE cells and thymocytes in a surface and antinuclear 
antibody pattern, VLA-4 reacted  with 8.2-wk thymocytes 
(although thymic vessels did not express V-CAM, a ligand 
for VLA-4,  until 13 wk), and VLA-6 mAb BQ16 reacted 
with thymic stroma throughout the 8.2-wk thymus (Fig. 
7). VLA-/31 (CD29) mAb K20 reacted with all thymus com- 
ponents throughout ontogeny (Fig.  7 D). 
Because it is often difficult to distinguish between thymic 
1450  Early Human T Cell Development Figure 4.  TCR-related molecule expression  in 8.2-wk 
human  thymus.  (A) cTCR-B expression with mAb 
BF1. (B) No reactivity with TCR-~ mAb BB3, which 
is specific  for V~52. The pan-TCR-~ mAb TCR.-~I was 
also nonreactive  (not shown).  (C) Rare V'y9 + cells 
in thymus with mAb TI~A. (/9) All thymocytes were 
CD3e +. The dark  area in the center of the thymus 
is tissue artifact. (E) Most thymocytes were also weakly 
CD36 + . (F) A rare 8.2-wk cell (arrowhead)  that was 
CD3~  "+ with mAb 2H2 with most thymocytes at 8.2 
wk CD3~'-.  x400. 
Table  3.  Expression  of TCR-associated Molecules During Early Human T  Cell Development 
Fetal  Molecule analyzed 
thymus 
no.  Age  CD3e  CD3~5  CD3~"  TCR-J3  TCR-'y  TCR-V'y9  TCR-~  TCR-V~51  TCR-V~52  V62/V~1 
wk 
58  8.2  100  100  0  5  0*  0*  0  0  0  0 
48  9.5  96  100  0  32  ND  ND  11.0  0.4  9.0  18 
22  10.0  100  100  0*  47  ND  0.1  4.0  0.4  6.0  15 
40  12.75  100  100  c + /  -  ,m +  69  ND  ND  1.0  1.0  8.0  8 
56  13.0  100  100  c + /  -  ,m +  60  ND  1.0  0.6  0.5  1.0  2 
5  15.0  99  100  ND  83  ND  ND  1.0  0.7  1.5  2 
57  16.0  100  100  c + /  -  ,m +  80  ND  1.0  1.3  0.1  1.4  5 
* Rare cells  + ; c + / -,  subset  of cortical  thymocytes  + ; m +, most medullary  thymocytes  +. 
Data for CD3e, TCR-B, and  TCR-~ are from reference  8.  ND, not done. 
1451  Haynes  and  Heinly § 
0  I  ,  I  ,  I  ,  I  ,  I  ,  I  ,  I  ,  I  ,  I  I.r  ~0  - 
I  0  12  14  16  18  20  22  24  26  28  post-  nalal 






Figure  5.  TCR4f cell development in human fetal thymus. The figure 
shows the percentage of TCR-~+ cells in fetal thymuses (solid circles) (data 
are from reference 8 and this study) and an analysis of the ratio of the 
number of V52 + (mAb BB3) to V51+  (mAb A13) cells (open circles). 
Analysis shows an initial peak in the percentage of TCR-~ cells at 9.5 
wk of gestation  (8) with most of the TCR-5 cells V/~2  + . By week 12, 
the percentage of TCR-/~ cells  decreased to 1-2% of total thymocytes, with 
V~2 + cells predominating throughout fetal thymus development. 
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Figure 6.  Expression of CD58, CD48,  CD99 
and 59 antigens in 8.2-wk fetal thymus. The figure 
shows analysis of 8.2-wk fetal thymus in indirect 
IF assay with mAbs against CD58 (TS2/9,  A), 
CD48 (6.28, B) CD99 (10F9, C), and CD59 (H19, 
D). Whereas CD2 was not expressed by thymo- 
cytes in 8.2-wk thymus (Fig. 3 F), a second ligand 
for CD58,  CD48, was expressed (A).  x400. Figure  7.  Expression  of adhesion molecules in 8.2-wk fetal thymus. (A) CD49a (VLA-1)  mAb reactivity with vessels within the thymus (right arrow- 
head) and with scattered thymic microenvironment  cells (left arrowhead). VI,  A-2 mAb 12F1 reacted with thymic stromal elements throughout the 8.2-wk 
thymus (B), whereas VLA-4  mAb B5G10  reacted with most thymocytes  (C). (D) Reactivity of CD29 (VLA-f31)  (mAb I(20) with both thymic stromal 
and thymocyte thymus components. (E and F) Reactivity of CD54 mAb (RR.1) and CDlla/CD18 LFA-1 (TS1/22) with 8.2-wk thymus. CD54 
expression was on central epithelium only (E), LFA-1  mAb TS1/22 reacted with mononuclear cells throughout the thymus (F). (G) Faint scattered 
cell reactivity with L-selectin mAb, LAM1.3; (H) lack of reactivity of 8.2-wk thymic vessels with  VCAM-1 mAb HAE2a. x400. 
stromal and thymocyte reactivity in tissue section IF assays, 
the reactivity of VLA-1, -2, -3, -4, -6, VLA-/31, CD59, CD99, 
and CD48 mAbs with postnatal  thymocytes and cultured 
TE cells was assayed  by use of flow cytometry on single-cell 
suspensions. VLA-2, VLA-3, and VLA-6 mAbs reacted with 
TE cells, and VLA-4 mAbs reacted only with thymocytes 
(21). VLA-1 mAb TS2/7 reacted weakly with TE cells grown 
in culture, while in tissue sections, only thymic vessels were 
VLA-1 + (this study and Patel, D. D., and B. F. Haynes, un- 
published observations). VLA-B1 mAb K20 reacted with both 
TE cells and thymocytes.  In cell  suspensions,  CD48  was 
thymocyte specific, while CD59 and CD99 mAbs reacted 
with both TE cells and thymocytes (not shown). 
From 9.5 wk through birth, VLA-2 mAb 12F1 reacted 
primarily with subcapsular cortical thymic epithelium, and 
VLA-4 mAb B5G10 remained thymocyte specific  (21). VLA-1 
mAb TS2/7 reacted with vessels and scattered stromal cells, 
and VLAq31 K20 mAb reacted with all thymus cell types. 
VLA-3 mAb A3-IIF5 reacted with thymic fibroblasts, vessels, 
and epithelium. VLA-6 mAb BQ16 reacted with TE cells, 
fibrous capsule, and vessels in fetal and postnatal  thymuses 
(not  shown). 
Analysis of Thymic Microenvironment  Components of 8.2-wk 
Fetal Thymus 58.  We have previously reported the analysis 
of thymic microenvironment components of thymuses of 9.5 
wk of gestation and older with many of the reagents listed 
in Table 1 (3, 22-26).  The key issues with the 8.2-wk fetal 
thymus were (a) Could separate endodermal (TE-3 +) (early 
cortical)  and ectodermal (TE-4 +,  p19 +) (early medullary) 
zones of TE cells  be visualized? (b) Were vessels  present within 
the parenchyma of the right and left 8.2-wk thymus? (c) Were 
macrophages and dendritic ceUspresent in the thymus at 8.2 
wk? and (d) Was there any evidence of myelopoiesis in the 
8.2-wk thymus? 
First, all 8.2-wk thymic epithelium was TE-3 +, whereas 
only  the  central  TE  zone  was  TE-4 +,  directly  demon- 
strating  that TE-4 medullary epithelium was located in an 
inner core of the thymus cylinder, and demonstrating that 
the TE-3 antigen, though preferentially expressed in cortical 
TE in postnatal  thymus (23), was equally expressed at 8.2 
wk in both cortical and medullary TE cells (Fig. 8, C and 
D). Thus, these data suggested that before thymus lobula- 
tion, there was a TE-4-  outer cortical (endodermal) epithe- 
lial zone surrounding a TE-4 + inner medullary (ectodermal) 
epithelial core. 
There were no vessels revealed  by morphology or antivessel 
mAb reactivity in the nonlobulated right thymus, but in the 
lobulated left thymus, there were vessels approaching  (Fig. 
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ment components  of human 8.2-wk fetal thymus. In 
all panels, the dotted line shows the outer border of 
the thymus.  (A)  Keratin-positive  epithelium  in  the 
right thymus with anti-keratin  mAb AE1. (B) The 
fight thymus expressed the endocrine epithelial gan- 
glioside antigen  A2B5. (C) Reactivity  of all thymic 
epithelium with mAb TE-3, whereas (D) only cen- 
tral TE cells of the fight thymus were TE4+. (E) An 
extrathymic bifurcating vessel (mAb V2) (arrowheads) 
just approaching the left thymus capsule (dotted line) 
with the thymus below  the dotted line. The arrow 
points out autofluorescent artifact. (F) Scattered Von 
Willebrand factor-positive endothelial cells within the 
left thymus,  x400. 
8 E) and within (Fig. 8 F) the thymus. In addition, thymus 
58 epithelium was keratin+p19 -  (mAb that binds a develop- 
mentally regulated keratin [22,  24,  Palker,  T. J.,  and B.  F. 
Haynes, unpublished observations]), TE-8+TE19 + (medul- 
lary TE only; 25), B7-  and A2B5 + (a marker of medullary 
TE;  26).  Connective  tissue  around  8.2-wk  TE  cells  was 
TE-7 + and tissue transglutaminase + . 
Papiernik et al. (27) have suggested that hematopoietic stem 
cells, upon entering the thymus, are driven to differentiate 
into thymic macrophages and dendritic cells as well as T cells. 
Kurtzberg et al.  showed CD7+CD3-CD4-CD8 -  thymo- 
cyte differentiation into myeloid as well as lymphoid lineages 
in vitro (28).  In 8.2-wk thymus 58,  no immature myeloid 
cells  were detected with  CD33  mAb MY9  (not  shown). 
CD14 + and CDllb + macrophages were present in 8.2-wk 
thymus, as  were CD16 + cells with  a similar morphology 
(not shown). No HB15a + dendritic cells were found in 8.2- 
wk  thymus.  Whereas  intrathymic  lymphocytes  were 
CD34-, scattered large cells with long cytoplasmic processes 
were CD34 +, and similar cells were seen around the spinal 
cord, aorta, fetal liver, and esophagus (not shown). CD34 + 
cells around the esophagus were CD4 - CD8 - CD7- CD44 + 
MO-1+HB15a-CD33-.  Thus,  cells  of monocyte/macro- 
phage lineage were present within human thymus coincident 
with colonization of the thymus by stem cells, and CD34 + 
CD44+MO-1 + cells were scattered around the esophagus, 
aorta, and spinal  cord.  However, no evidence of active  in- 
trathymic myelopoiesis was seen. 
Discussion 
In this study, we have used a large panel of anti-human 
mAbs to define phenotypic and morphologic events that tran- 
spire  during the earliest stages  of human thymus develop- 
ment, and have outlined the developmentally regulated ex- 
pression of a number of functional T  cell molecules. 
Auerbach (29) has proposed that TE cell-fibroblast inter- 
actions occur during thymus development that provide po- 
tent stimulatory signals  to TE cell growth.  Nonlymphoid 
thymuses in human SCID are dysplastic due to lack of  coloni- 
zation of the thymus by stem cells  (30).  Early work with 
bone marrow reconstitution in human SCID suggested an 
inductive effect of hematopoietic stem cells on thymic epi- 
thelial proliferation (31). Recent work with transgenic mice 
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cell growth on the presence of thymocytes in the thymus 
(for review see reference 32). Thus, the striking 35-fold in- 
crease in volume of the 8.2-wk (colonized) thymus compared 
with the 7-wk nonlymphoid thymus was expected.  What 
was unexpected was the globular shape and the intertwined 
upper poles of the 8.2-wk right and left thymus lobes. 
We have previously shown that one adhesion ligand pair 
involved in TE cell ligation of thymocytes is CD2 on thymo- 
cytes and CD58  (LFA-3) on TE cells (33,  34).  Although 
CD2-LFA-3 interactions have been postulated to be impor- 
tant in triggering TCR-  early T cells (35), CD2-homolo- 
gous recombinant mice show no defect in T  cell develop- 
ment (36), and treatment of mice with anti-CD2 mAbs early 
in life does not interfere with thymopoiesis (37). Nonethe- 
less, we and others (3-5) have generally regarded CD2 among 
the earliest T cell molecules expressed on developing T cells 
in the thymus. Thus, it was surprising that CD2 expression 
was not detected in 8.2-wk thymus with two CD2 mAbs 
(35.1 and OKTll) (Fig. 2 F) that reacted well with thymuses 
from other  gestational  ages. Importantly, CD2-  surface 
(s)CD3e + fetal thymocytes have been identified in 20-24-wk 
thymuses, demonstrating that during human fetal thymus 
development, it is not obligatory for CD2 to be expressed 
surface sCD3/TCR expression (38). Our study shows that 
after stem cell colonization of the human thymus, CD3, CD8, 
CD3e, CD3~, CD48, and TCR-fl expression all precede CD2 
expression. Arulanandam et al. (15) demonstrated that human 
CD48 is a weak ligand for CD58, and suggested that CD48- 
CD58 interactions in man are vestigial events left over from 
the primary role CD48 plays as a CD58 ligand in other spe- 
cies such as mice. The demonstration that CD2 was not ex- 
pressed in human thymus at the initiation of thymopoiesis 
provides evidence that, if CD58 ligation is important at this 
stage of thymus development, CD48-CD58 interactions may 
be involved in thymocyte-thymic stromal interactions. 
The sequential acquisition of CDSo~ (8.2 wk) followed by 
CDSfl (9.5-10 wk) is consistent with the work of Galy et 
al. (39), who described an early T cell maturation pathway 
in sCD3-  postnatal thymocytes of CD8-  to CDSc~  + to 
CDSodfl + thymocytes. CD8o~ associates with p56-1ck and 
is critical for CD8 + thymic-positive selection on MHC class 
I molecules (40), CDSfl expression augments TCR-MHC 
class I interactions above the effects of CD8ot (41), but the 
role of CDSfl in thymocyte-positive selection is not known. 
If CD8fl is required for CD8 + T cell selection, then the ac- 
quisition of CD8fl expression at 9.5-10 wk implies that MHC 
class I-mediated selection does not occur until this time. Simi- 
larly, CD28 expression  first occured at 10 wk, and CD28 
has been postulated to be required for thymocyte-positive se- 
lection (42), though not for thymocyte-negative selection (43). 
The gradual acquisition of medullary thymocyte CD45RA 
expression at 10-12.75 wk also implies the gradual onset of 
positive selection.  CD45P,  A + thymocytes have been sug- 
gested to be those destined to survive intrathymic selection 
events (12). Recently, studies in transgenic mice demonstrated 
that CD45RA expression is induced on thymocytes that have 
undergone positive selection (44). Conversely, expression of 
CD45RO by thymocytes increases the efficacy  of TCR-medi- 
ated thymocyte apoptosis and MHC-restricted negative se- 
lection (14, 45). Thus, CD45P,  O  expression at 9.5-10 wk 
suggests that thymocyte negative selection could begin at the 
same time as positive selection or just before. TCR-mediated 
signaling not only requires CD45 tyrosine phosphatase ex- 
pression but also requires expression of CD3~" (46). Acquisi- 
tion of CD3~" between 10 and 12.75 wk also implies that 
thymocyte selection does not begin to occur until this time. 
The sequence of expression of TCR-fl, TCR-y, and then 
TCR-6 is similar to that seen in mice, with two important 
differences. First, in the mouse there is a wave of TCR-'y/8 
cell  development before TCR-ot/fl  cell  development (for 
reviews see references 1, 47). In human thymus, TCR-/~ cells 
peak in percentage at 9.5 wk of fetal development (4). How- 
ever, in humans, appearance of TCR-8 cells in thymus coin- 
cides with increasing TCR-fl and sTCR-ol/fl expression (3-5, 
48). Thus, in humans there is near-coincident appearance of 
TCR-6 and -cz/fl  thymocytes. Our observations of TCR 
V82 + cell predominance over TCR V/~I + cells throughout 
fetal thymic development are compatible with the observa- 
tions of others (49-51),  who found that TCR V/~2  + expres- 
sion in T cell clones from 11-22-wk fetal thymuses predomi- 
nated over TCR V81. Parker et al. (52) proposed that TCR 
V62 + cells develop in the thymus during fetal  gestation, 
seed the periphery, and clonally expand upon contact with 
antigen. 
Second, in the 8.2-wk human thymus, TCR-fl synthesis 
begins simultaneously with T cell precursor colonization of 
the thymus, whereas in the mouse, TCR-fl synthesis begins 
around day 15, 5 d after mouse thymus colonization by stem 
cells (53).  It has recently been demonstrated in mice that 
TCR-fl can be expressed on the developing thymocyte sur- 
face either as a dimer or associated with a novel protein, gp33, 
as well as expressed in an ot/fl heterodimer (for review see 
reference 54). Due to the small size of the 8.2-wk thymus 
(<1 mm3), we were limited to phenotypic analysis of the 
thymus in situ via IF assays on tissue sections, thus negating 
our  ability  to  definitively  distinguish surface  from cyto- 
plasmic(c) mAb reactivity. In the mouse, all thymocytes are 
sCD4- sCD8- from the time of colonization of the murine 
thymic rudiment on day 10-11 until day 16-17 (10, 11). Levelt 
et al. (53) demonstrated that cytoplasmic expression of mu- 
rine TCR-fl begins on day 15, with 3,5%  of thymocytes 
cTCR-fl + before expression of CD4 or CD8. Thus, the 8.2- 
wk human thymus is similar to murine day 15 thymus in 
that 8.2-wk thymus TCR-3 expression (5%) is likely cyto- 
plasmic, but differs from mouse thymus in that most human 
thymocytes  just after thymus colonization express CD4 and 
CD8, whereas day 15 mouse thymocytes are CD4-CD8- 
(10,  11, 53). 
Our previous work has shown that by 16 wk of gestation, 
CD4,CD8,CD3e and TCR-fl were expressed in fetal thymus 
in patterns similar to postnatal thymus, and gave rise to the 
prediction that the T cell repertoire is established in humans 
by the end of the first trimester (22). Recent molecular anal- 
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of gestation  have shown  no  difference from  the  newborn 
thymus VB repertoire  (55-57). 
Terminal deoxynucleotidyl transferase (TdT) is a DNA poly- 
merase that functions in the absence of a template to act as 
a somatic mutagen by the insertion of extra random nucleo- 
tides (N regions) at the D-J joining region during TCR-~/ 
rearrangements,  contributing  to TCR-/3 diversity. TdT ex- 
pression was not found by immunohistology in human thymo- 
cytes until 20 wk of gestation (48).  However, George and 
Schroeder (57) found TCR N  region  additions  as early as 
8 wk of gestation with PCR identification of TdT transcripts, 
and  demonstrated  progressive increases  in  N  additions  in 
TCR-3,  CDR3, VD, and VDJ transcripts  during fetal de- 
velopment. Whether the 8-wk tissue in this latter study was 
as early as tissue 58 in our study (i.e.,  was a nonlobulated 
thymic rudiment) is unknown since morphologic data were 
not reported (57).  Nonetheless,  all data point  to initiation 
of diversification of the TCR repertoire very early on in hu- 
man  T  cell ontogeny. 
Investigators  have isolated  CD4-CD8-sCD3E-  cells from 
human fetal liver and postnatal thymus and shown that they 
give rise to CD3~ +  CD3b + NK cells, suggesting a dose lin- 
eage relationship between T and NK calls (58, 59). We did 
not observe a stage of human thymic development wherein 
a majority of thymocytes expressed NK markers such as CD16 
or CD56,  although  scattered CD16 + cells were present in 
thymus at  8.2 wk. 
The expression of VLA 1-6 in thymus development be- 
ginning  at  15 wk has  been previously reported  (21).  New 
in our study is the demonstration  of reactivity of VLA-1, 
-2, -3, -4, -6, and B1 mAbs on 8.2-wk thymus. Sanchez et 
al. (60) have demonstrated VLA-4 expression on T cell pro- 
genitors in human fetal liver, and TE cells may bind certain 
thymocyte subsets via VLA-4 (Le, P. T., personal communi- 
cation).  A  number of integrin  molecules have been postu- 
lated to be involved in stem cell migration to the human thymic 
rudiment, but this question is difficult to directly address ex- 
perimentally. 
Our  study identified the organization  of TE-4 + central 
medullary thymic epithelium surrounded by TE-4-  cortical 
epithelium  in the 8.2-wk thymus.  The gradual  appearance 
of CD45RA § cells in central thymic areas, and the expres- 
sion of CD6 and CD28 in thymocytes in central TE areas, 
also suggested that the primordial thymic medulla is the central 
core of the 8.2-wk thymic rudiment that has begun to orga- 
nize immediately subsequent to thymus colonization.  In a 
separate  study, we have found that MHC class I and II allo- 
typic determinants are also expressed brightly in the central 
8.2-wk thymus area-a pattern typical of medullary TE cell 
MHC expression (Haynes, B. F., unpublished observations). 
Finally,  it was of interest to observe CD34 + cells around 
the aorta,  spinal cord, and esophagus at 8.2 wk.  Recently, 
two groups have suggested that mesoderm around the dorsal 
aorta,  gonads, and mesonephros (AGM) areas of mice, and 
not yolk sac, provide the source of stem cells before fetal liver 
development (61).  Whereas no functional data are possible 
from our study, one explanation for the presence of CD34 + 
cells in the dorsal thorax of 8.2-wk fetal  tissue is that  this 
area may be analogous to the AGM mesoderm in mice (61). 
Thus, our study has defined phenotypic and morphologic 
changes that occur in and around the human thymus at the 
time of colonization of the thymus by hematopoietic stem 
cells. This study raises a number of important  questions re- 
garding human thymus function, including the nature of the 
role of CD48-CD58 interactions in early T cell development, 
the significance of developmentally regulated thymocyte CDlb, 
-c,  -a  expression,  the  regulatory  mechanisms  involved  in 
CD83, CD28, and CD6 expression, and the functional roles 
integrins  play in early intrathymic  maturation. 
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